Previous Article | Next Article ![]()
Journal of Bacteriology, April 2007, p. 3147-3155, Vol. 189, No. 8
0021-9193/07/$08.00+0 doi:10.1128/JB.01868-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Luis R. Cruz-Vera, and
Charles Yanofsky*
Department of Biological Sciences, Stanford University, Stanford, California
Received 12 December 2006/ Accepted 31 January 2007
|
|
|---|
, resists cleavage, resulting in ribosome stalling at the tnaC stop codon. This stalled ribosome blocks Rho factor binding and action, preventing transcription termination in the tna operon's leader region. Plasmid-mediated overexpression of tnaC was previously shown to inhibit cell growth by reducing uncharged
availability. Which factors relieve ribosome stalling, facilitate TnaC-
cleavage, and relieve growth inhibition were addressed in the current study. In strains containing the chromosomal tna operon and lacking a tnaC plasmid, the overproduction of ribosome recycling factor (RRF) and release factor 3 (RF3) reduced tna operon expression. Their overproduction in vivo also increased the rate of cleavage of TnaC-
, relieving the growth inhibition associated with plasmid-mediated tnaC overexpression. The overproduction of elongation factor G or initiation factor 3 did not have comparable effects, and tmRNA was incapable of attacking TnaC-
in stalled ribosome complexes. The stability of TnaC-
was increased appreciably in strains deficient in RRF and RF3 or deficient in peptidyl-tRNA hydrolase. These findings reveal the existence of a natural mechanism whereby an amino acid, tryptophan, binds to ribosomes that have just completed the synthesis of TnaC-
. Bound tryptophan inhibits RF2-mediated cleavage of TnaC-
, resulting in the stalling of the ribosome translating tnaC mRNA. This stalling results in increased transcription of the structural genes of the tna operon. RRF and RF3 then bind to this stalled ribosome complex and slowly release TnaC-
. This release allows ribosome recycling and permits the cleavage of TnaC-
by peptidyl-tRNA hydrolase. |
|
|---|
for general protein synthesis (9). This deficiency was caused by the accumulation of uncleaved TnaC-
within stalled, translating ribosomes (9). Growth inhibition was relieved by overproducing
(9). During the biosynthesis of polypeptides in bacteria, amino acid assembly is terminated when the mRNA stop codon of a coding region is encountered in the A site of the 70S ribosomal complex. The nascent polypeptide chain is then cleaved from its associated tRNA in a factor-dependent manner. The translating ribosome with the deacylated tRNA initially remains bound to mRNA and is subsequently separated by the action of accessory translation factors (13, 15). Six different factors are known to participate in the translation termination process: (i) release factors RF1 and RF2 (these factors are responsible for the recognition of the three stop codons and for activating the cleavage of each peptidyl-tRNA) (26), (ii) release factor RF3 (this factor increases the rate of dissociation of RF1 and RF2 from the ribosome following polypeptide release) (4, 32, 33), (iii) ribosome recycling factor (RRF) (this factor is responsible for ribosome separation from a transcript, and it releases the mRNA and tRNA from the ribosomal complex) (14), (iv) elongation factor G (EF-G) (this factor and RRF are believed to be jointly responsible for recycling bacterial ribosomes following the termination of polypeptide synthesis) (13), and (v) translation initiation factor IF3 (this factor prevents the reassociation of the dissociated ribosomal subunits by binding to the transiently formed 30S subunit during or following the action of RRF and EF-G) (13, 16, 27).
In addition to the normal mechanism of translation termination, there are two auxiliary mechanisms that bacteria use to hydrolyze a peptidyl-tRNA: the action of peptidyl-tRNA hydrolase (Pth) (19) and the participation of tmRNA (17). An uncleaved peptidyl-tRNA may be released from a stalled ribosome by a phenomenon called peptidyl-tRNA dropoff (21). The peptidyl-tRNA liberated is hydrolyzed by Pth, separating the peptide from its tRNA (19). It has also been reported that nascent peptide chains encoded by truncated mRNAs containing contiguous rare codons, or containing an inefficient stop codon, are targeted and tagged by the action of tmRNA (17, 24, 25). When trans-translation is completed, the unfinished peptide or polypeptide will have an 11-amino-acid-residue tag (AANDENYALAA) added at its carboxy-terminal end. This tag and its associated peptide or polypeptide are subjected to rapid degradation by various cellular proteases (10, 17). This process allows a translating ribosome to be recycled so that it may participate in a new round of protein synthesis (23).
In this study, various plasmids were used to overproduce the different translation factors, and in vivo levels of TnaC-
and free
were continuously monitored. The assay procedure used to measure the levels of TnaC-
was developed previously (9). Our data indicate that when tnaC is overexpressed in the presence of tryptophan, (i) RF2 action is prevented, (ii) RRF and RF3 cause TnaC-
dropoff, (iii) the released TnaC-
is cleaved by Pth, (iv) RRF and RF3 promote ribosome recycling, and (v) RRF, RF3, and Pth action relieves the growth inhibition caused by
depletion. tmRNA did not act on tryptophan-induced stalled ribosome complexes containing TnaC-
. Under normal induction conditions, in strains lacking a tnaC plasmid, the extent of TnaC-
accumulation is insufficient to cause growth inhibition. However, RRF and RF3 appear to play the same role, promoting TnaC-
dropoff and ribosome recycling. This allows the released
and freed ribosome to participate in new rounds of protein synthesis.
|
|
|---|
2::kan] was prepared by P1 transduction. |
View this table: [in a new window] |
TABLE 1. Bacterial strains and plasmids
|
![]() View larger version (36K): [in a new window] |
FIG. 2. tnaC overexpression does not affect the half-life of TnaC- in vivo. Strain SVS1144 (A) or SVS144 harboring plasmid pTnaC (B) was grown at 37°C in minimal medium supplemented with 0.05% acid-hydrolyzed casein and 0.2% glycerol with (+) or without () the addition of 100 µg/ml tryptophan (Trp). The OD600 at the time of glucose addition (final concentration of 1.0%) to each culture was 0.6 to 0.8. Samples were taken at the indicated times, harvested by centrifugation, and disrupted by sonication, and equivalent amounts of total protein were electrophoresed on a 10% Tricine-sodium dodecyl sulfate acrylamide gel. Northern blotting was then performed to quantify the level of TnaC- (TC-tRNAP). The TnaC- band was detected at 26 kDa. The (tRNAP) molecule was also detected at 14 kDa; however, measurements of levels were not accurate quantitatively (10). The measured half-life (t1/2) of TC-tRNAP, calculated using the curves in C, is given to the right of each set of data. Little or no TnaC- was detected in the samples from uninduced cultures. The percentage of TnaC- relative to the level at 0 min was calculated by dividing the densitometry units obtained from the TnaC- band in each lane by the units obtained for the TnaC- band in the 0-min lane. Note that there is less TnaC- in the 0-min sample from chromosomal tnaC expression (compare +Trp TC-tRNAP values in A with those in B). (C) Plot of TnaC- decay curves based on the data shown in A and B. Plots are not shown for the cultures grown without tryptophan. At least three independent experiments were performed, and the TnaC- values obtained for any strain and condition varied by less than 20%.
|
ß-Gal assays. ß-Galactosidase (ß-Gal) assays were performed on cultures grown with shaking at 37°C in minimal medium with or without 100 µg/ml tryptophan and with or without 10 mM isopropyl-ß-D-thiogalactopyranoside (IPTG). ß-Gal assays were performed as described previously (22); ß-Gal activity is reported in Miller units.
Measurement of levels of TnaC-
in vivo.
Various E. coli strains, several bearing the plasmids listed in Table 1, were grown in appropriate media at 30°C, 37°C, or 42°C. Cells were harvested at an OD600 of 0.8. The levels of TnaC-
in samples taken from each culture were determined by preparing sonic extracts, centrifugation, and analysis of equal amounts of protein in the supernatants by electrophoresis and Northern blotting. The probe used was unique to
. The procedures used have been described previously (9). TnaC-
and
were detected as bands at 26 kDa and 14 kDa, respectively, under the conditions used (9). For quantification, each gel was exposed to films for different lengths of time, the developed films were scanned, and values were compared to ensure the accuracy of the final values (densitometry imager; Bio-Rad). The band densities (densitometry units) were determined using imaging software (Molecular Analysis; Bio-Rad).
|
|
|---|
|
View this table: [in a new window] |
TABLE 2. TnaA-LacZ expression by strain SVS1144 containing different combinations of plasmids expressing mutant and nonmutant translational factorsa
|
for continued protein synthesis was reduced (9). This was due to the accumulation of uncleaved TnaC-
within the ribosomes translating tnaC mRNA (9). This inhibition was relieved upon
overproduction (9). If the overproduction of RRF and RF3 could promote TnaC-
cleavage, their overproduction would be expected to relieve the growth inhibition resulting from TnaC-
accumulation (9). To examine this possibility, it was necessary to overproduce TnaC, RRF, and RF3 in the same bacterium. To achieve this objective, the frr gene (encoding RRF), driven by its own promoter, pfrr, was inserted into plasmid pTnaC immediately following the rpoBC terminator sequence (Fig. 1A). After confirming the location and sequence of the DNA insert, the overproduction of RRF in vivo was verified by Western blotting using anti-RRF antibodies. The amount of RRF produced was estimated to be three- to fourfold greater than that produced by the control strain (data not shown). Reverse transcription-PCR analyses also indicated that there was a 2.5-fold increase in tnaC mRNA in strains with the tnaC plasmid and that the insertion of the frr gene and its promoter had no effect on the level of tnaC mRNA (data not shown). SVS1144 strains transformed with plasmids (i) pTnaC, (ii) pTnaC and pIQ-RF3, (iii) pTnaC-RRF, and (iv) pTnaC-RRF and pIQ-RF3 were grown in supplemented minimal medium with or without 100 µg/ml tryptophan and with or without 10 mM IPTG (Fig. 1B). The production of RF3 by plasmid pIQ-RF3 is dependent upon the presence of the inducer, IPTG (the RF3 level has been reported to increase 10-fold when 10 mM IPTG is present in the growth medium) (20). Our results indicate that the growth inhibition caused by the presence of plasmid pTnaC in strains grown in the presence of tryptophan was relieved only when both RRF and RF3 were overproduced in transformants containing both plasmids pTnaC-RRF and pIQ-RF3 grown with 10 mM IPTG (Fig. 1B). Transformants overproducing RRF or RF3 alone did not exhibit relief from this growth inhibition (Fig. 1B). These findings demonstrate that an excess of both factors RRF and RF3 is necessary in order to reverse the growth inhibition caused by plasmid-mediated tnaC overexpression in strains grown in the presence of tryptophan.
![]() View larger version (23K): [in a new window] |
FIG. 1. Overproduction of RRF and RF3 relieves the growth inhibition caused by tnaC overexpression. (A) Schematic representation of the organization of plasmids pTnaC and pTnaC-RRF. Both plasmids are pUC18 derivatives and contain the tna operon promoter, the tnaC open reading frame, the noncoding region located between tnaC and tnaA genes, and an added rpoBC terminator. In preparing pTnaC-RRF, a fragment containing the RRF coding region and its own promoter from plasmid pRR1 was subcloned into plasmid pTnaC immediately following the rpoBC terminator. (B) Overproduction of both RRF and RF3 relieves the growth inhibition caused by tnaC overexpression by pTnaC in the presence of tryptophan. E. coli cells bearing the different plasmids listed in the figure (Table 1) were diluted from cultures grown overnight and were grown with shaking at 37°C in minimal medium supplemented with 0.05% acid-hydrolyzed casein and 0.2% glycerol with (+) or without () 100 µg/ml tryptophan (Trp). Cell growth was monitored at an OD600. A total of 10 mM IPTG (+) was added at time zero for RF3 overproduction. Four independent growth experiments were performed. The growth curves for the different strains grown with or without added tryptophan were all similar to those shown in this figure.
|
is 8 min under induction conditions in vivo.
Cultures of strain SVS1144 with or without pTnaC (Table 1), a plasmid overexpressing tnaC, were grown to an OD600 of 0.6 to 0.8 in supplemented minimal medium in the presence or absence of 100 µg/ml tryptophan. Glucose was then added to each culture (final level, 1%) to inhibit the initiation of transcription of the tna operon, and portions of each culture were harvested at the times indicated (Fig. 2). The levels of TnaC-
were then measured, and its half-life was determined (Fig. 2). The parental SVS1144 culture, expressing tnaC chromosomally, when grown in the absence of tryptophan, had no detectable TnaC-
(Fig. 2A). When grown in the presence of tryptophan, its TnaC-
level in the sample at time zero was low, and its half-life was approximately 8 min (Fig. 2A and C). In previous in vitro-coupled transcription-translation assays performed with RF2-deficient cell extracts, it was shown that the transcription of tnaC and translation of tnaC mRNA were not affected by the absence of tryptophan (8). Thus, the absence of detectable TnaC-
in cultures grown without tryptophan is probably due to its rapid cleavage; its half-life under these conditions is presumably <8 min. When strain SVS1144 containing plasmid pTnaC was grown in the presence of tryptophan, the TnaC-
half-life was also approximately 8 min (Fig. 2B and C). In the absence of tryptophan, no TnaC-
was detected; therefore, its half-life is presumably <8 min. These findings demonstrate that under induction conditions, with or without tnaC overexpression, TnaC-
accumulates. However, it is eventually hydrolyzed, yielding TnaC and
. The freed
and ribosomes thus would become available for additional protein synthesis.
Overproduction of RRF and RF3 in a strain overexpressing tnaC reduces TnaC-
accumulation and shortens its half-life.
Next, experiments to determine if the stability of TnaC-
was affected in strains containing plasmid pTnaC when RF3 and/or RRF was limiting or overproduced were performed (Fig. 3). Cultures of wild-type and mutant strains with plasmid pTnaC were grown at 37°C in supplemented minimal medium in the presence of 100 µg/ml tryptophan to an OD600 of 0.6 to 0.8. At this temperature, it was observed by Western blot analysis that the RRF level is reduced in strains containing frr(Ts) (data not shown). Glucose was then added to each culture (final level, 1%) to shut off tna operon transcription initiation. Portions of each culture were harvested at the times indicated, and the level and half-life of TnaC-
were measured (Fig. 3). In the control culture containing plasmid pTnaC (SVS1144 plus pTnaC), the TnaC-
half-life was approximately 8 min. When either RF3 (pIQ-RF3) or RRF (pTnaC-RRF) was overproduced alone in strains with pTnaC, the TnaC-
half-life was reduced from 8 min to 7 min and from 8 min to 4 min, respectively (Fig. 3A and B). When both RRF and RF3 were overproduced in the same cell, the half-life of TnaC-
was reduced further, to 2 min (Fig. 3A and B). In pTnaC strains producing a temperature-sensitive RRF protein [frr(Ts)] incubated at 37°C for 1 h after shifting from 30°C, the half-life of TnaC-
was increased only slightly (Fig. 3A and B). A similar result was observed with a strain lacking the RF3 protein (prfC
2::kan) (Fig. 3A and B). However, when both RRF and RF3 were limiting {strain SVS1144[frr(Ts) prfC
2::kan] plus pTnaC}, the half-life of TnaC-
was increased appreciably, from 8 min to 20 min (Fig. 3A and B). These findings demonstrate that changing the levels of these two factors, RRF and RF3, has the most profound effect on the half-life of TnaC-
. Consistent with this conclusion and the calculated half-lives are the levels of TnaC-
detected in the 0-min samples that were analyzed (Fig. 3A, second column). These 0-min levels reflect the sensitivity of TnaC-
to cleavage in the respective strains. The half-life of TnaC-
was also examined in strains overproducing other translational factors such as EF-G and IF3; these had no observable effects (data not shown).
![]() View larger version (40K): [in a new window] |
FIG. 3. Overproduction of RRF and RF3 reduces the half-life of TnaC- in vivo. (A) Strains bearing the indicated plasmid or plasmids were grown at 30°C or 37°C in minimal medium supplemented with 0.05% acid-hydrolyzed casein and 0.2% glycerol with the addition of 100 µg/ml tryptophan (Trp). In strain SVS1144(prfC 2::kan), the prfC gene was deleted. Strain SVS1144[frr(Ts)] produces an RRF protein that is temperature sensitive. The frr(Ts) allele was also present in SVS1144[frr(Ts) prfC 2::kan]. Strains with plasmid pIQ-RF3 were grown with 10 mM IPTG, which induces RF3 production. Plasmid pTnaC-RRF was used to overexpress tnaC and overproduce RRF. Strain SVS1144[frr(Ts)] pTnaC was grown initially at 30°C and then shifted to 37°C for 1 h. Presumably, most of its RRF protein would be inactivated during growth at 37°C. The OD600 at the time of glucose addition (final concentration of 1.0%) to each culture was 0.6 to 0.8. Samples were taken and sonicated, and Northern blot assays performed to detect TnaC- (TC-tRNAP) and (tRNAP), as indicated in the legend of Fig. 2. The half-life (t1/2) of TnaC- , calculated using the curve in C, is shown to the right of each set of data. The relative TnaC- level at 0 min is shown to the left of each panel. These values were calculated by dividing the densitometry units obtained for the TnaC- band in each 0-min lane by the densitometry units obtained for the TnaC- band in the 0-min lane for the control SVS1144(pTnaC) culture. (B) The TnaC- decay curves are based on the percentage of TnaC- detected relative to the 0-min value, as indicated in Fig. 2. At least three independent experiments were performed, and the TnaC- values obtained for any strain and condition varied by less than 20%.
|
.
When the synthesis of a peptidyl-tRNA is completed, either it is hydrolyzed in response to the action of one of the release factors or, if peptidyl-tRNA dropoff occurs, it is cleaved by Pth (21). Since the presence of tryptophan inhibits RF2-initiated hydrolysis of TnaC-
, we wished to determine if the slow cleavage of TnaC-
observed under tryptophan induction conditions was due to peptidyl-tRNA dropoff and Pth cleavage. The stability and half-life of TnaC-
were determined in strains C600 and C600[pth(Ts)] as well as in strains C600 pTnaC and C600[pth(Ts)] pTnaC grown at 42°C (Fig. 4). These strains were grown under conditions chosen to maximally reduce the level of the Pth enzyme. Cultures were initially grown at 30°C in LB broth, a medium rich in tryptophan, to an OD600 of 0.8 (mid-log phase). The cultures were then shifted to 42°C for an hour of additional growth, with the objective of reducing the cellular level of the Pth(Ts) protein (3). Glucose was then added, and cell samples were harvested at the times indicated. The TnaC-
level was then determined. In wild-type strain C600 grown at 42°C, the half-life of TnaC-
was 11 min. A similar value was obtained for strain C600 pTnaC; the half-life of its TnaC-
was 9 min. (Fig. 4, compare A and B; also see Fig. 4C). When the TnaC-
half-life was determined in mutant strains C600[pth(Ts)] and C600[pth(Ts)] pTnaC grown at 42°C, half-life values greater than 20 min were calculated for both strain (Fig. 4, compare A and B; also see C). These findings indicate that TnaC-
was essentially uncleaved in these strains during the 20-min test period. This important result indicates that peptidyl-tRNA dropoff followed by Pth cleavage is primarily responsible for the processing of this peptidyl-tRNA under these conditions.
![]() View larger version (37K): [in a new window] |
FIG. 4. Pth (peptidyl-tRNA hydrolase) is responsible for the cleavage of TnaC- in vivo. Cultures of strains C600 (wild type) and C600[pth(Ts)] (temperature-sensitive Pth) either without (A) or with (B) plasmid pTnaC (+pTnaC) were grown in LB medium {C600[pth(Ts)]} at 30°C to an OD600 of 0.8. They were then shifted to 42°C and incubated for 1 h. Glucose was then added to 1%, and samples were harvested at the indicated times. Cultures of wild-type (wt) strain C600 grown at 42°C were used as controls. Northern blot assays were performed to detect TnaC- (TC-tRNAP) and (tRNAP), and the percentage of TnaC- detected relative to the 0-min value was calculated as described in the legend of Fig. 2. The half-life (t1/2) of TnaC- , calculated using the curve in C, is shown to the right of each set of data in A and B. (C) TnaC- decay curves based on the data in A and B. At least two independent experiments were performed, and the TnaC- values obtained for any strain and condition varied by less than 15%.
|
|
|
|---|
, creates a tryptophan binding site in the ribosome at which bound tryptophan inhibits TnaC-
cleavage (1, 2, 6). This uncleaved TnaC-
is temporarily retained within the translating ribosome, stalling its movement (7, 9). This stalling at the tnaC stop codon blocks Rho factor binding to tna operon leader RNA, thereby permitting a paused RNA polymerase to continue transcription into the structural genes of the tna operon (7). It has also been shown that tryptophan induction in strains containing a plasmid overexpressing tnaC results in the retention of sufficient uncleaved TnaC-
within the translating ribosome to create a
deficiency (9). This deficiency reduces the cell growth rate. Providing additional uncharged
was shown to restore normal growth (9).
If tryptophan induction of tna operon expression led to permanent ribosome stalling, induced cells would suffer from the accumulation of inactive ribosomes and a deficiency of
. In previous studies, the half-life of TnaC-
in cultures grown under inducing conditions was observed to be 10 to 15 min, implying that E. coli employs some natural mechanism to cleave the accumulated TnaC-
(9). In the present study, the mechanisms used by E. coli to release and cleave ribosome-bound TnaC-
were investigated. It was found that when tnaC was overexpressed in vivo, increased production of RRF plus RF3 reduced the half-life of TnaC-
from 8 min to 2 min (Fig. 3). It was also observed that the inactivation of RRF in a temperature-sensitive frr mutant and the deletion of prfC, the structural gene for RF3, stabilized TnaC-
appreciably; its half-life increased from 8 min to >20 min (Fig. 3). It was further established that the principal means of cleavage of TnaC-
was by the action of the enzyme Pth following TnaC-
dropoff from the translating ribosome. In a mutant producing a temperature-sensitive Pth grown at an elevated, nonpermissive temperature, the TnaC-
produced was essentially stable (Fig. 4). This stability was observed regardless of whether tnaC was expressed chromosomally or was overexpressed from a plasmid (Fig. 4). These findings suggest that the peptidyl-tRNA dropoff mediated by RRF and RF3 action is the normal mechanism employed by E. coli to relieve tryptophan-induced ribosome stalling at the tnaC stop codon. Dropoff presumably makes the TnaC-
available for Pth cleavage, and this cleavage provides additional
for protein synthesis. RF2 does not appear to play a major role in activating (or inhibiting) TnaC-
cleavage under tryptophan induction conditions (data not shown). Rather, RRF and RF3 appear to bind to TnaC-
-stalled ribosomes and release the TnaC-
. This would free the previously stalled ribosomes and permit Pth to cleave the TnaC-
.
E. coli is known to use at least three procedures to promote the release of a ribosome stalled at a sense or stop codon: (i) the action of the release factor RF1 or RF2 (26), (ii) RRF/RF3-mediated peptidyl-tRNA dropoff (28), and (iii) trans-translation by tmRNA (17). The in vivo and in vitro experiments described previously suggest that RF2 is ineffective in releasing ribosomes stalled at the tnaC UGA stop codon following the synthesis of TnaC-
. This is due to bound tryptophan preventing RF2 action (6). Rather, as shown in this study, RRF and RF3 appear to promote TnaC-
dropoff from the ribosome, and this peptidyl-tRNA is then cleaved by Pth.
The possible action of tmRNA on ribosome-bound TnaC-
was also studied in vivo and in vitro (data not shown). It was found that tmRNA was incapable of attacking ribosomes containing TnaC-
in vivo (overexpression of tmRNA had no observable effect on the ß-Gal [TnaA-LacZ] level in induced cells) (Table 2). tmRNA action was also examined in vitro using two truncated inducible and noninducible (Trp12 replaced by Arg12) tnaC mRNAs (data not shown). In both transcripts, the UGA stop codon of tnaC was replaced by UU, with these nucleotides at the 3' end of the transcript. In reactions performed in the absence of added tryptophan, tmRNA was able to attack the TnaC peptidyl-tRNA produced from either transcript. However, when tryptophan was added, it blocked tmRNA action on the inducible transcript but not on the noninducible transcript. These data provide additional support for the conclusion that Trp12 of TnaC is essential for tryptophan binding and inhibition of TnaC-
cleavage; they also indicate that tmRNA is not involved in TnaC-
metabolism.
In other unpublished studies, Feng Gong, then in our laboratory, and Akira Kaji showed that RRF plays a role in determining the level of expression of a noninducible tna operon. They found that the expression of a noninducible tnaA'-'lacZ fusion increased when RRF was limiting. They performed these studies using a plasmid with a mutant tnaC gene with the Trp12-to-Arg12 codon replacement. This result suggests that in the absence of RRF, a ribosome translating the tnaC Arg12 sequence is not liberated normally from the tnaC stop codon. It was also shown previously that the overproduction of RF3 influences the expression of tnaA of E. coli; however, the explanation for this observation was not known at that time (31). Previous studies also showed that RRF and RF3 were involved in peptidyl-tRNA dropoff from a translating ribosome (12, 28). In vitro analyses have also suggested that a disruption of prfC, or a down-regulation of RRF expression, results in a decreased rate of peptidyl-tRNA dropoff (12). It was also shown that RF3 can substitute for EF-G in RRF-dependent ribosome recycling reactions in vitro, during the dropoff of a short peptidyl-tRNA (11). The cryoelectron microscopy structure of the translating ribosome suggests that RF3 may induce a conformational change in the ribosome that facilitates the binding of RRF (18). In our studies, other factors such as EF-G or IF3 had no observable effects on either basal or induced tna operon expression (Table 2).
On the basis of studies performed previously by others and the results described in this paper, we propose the following explanation for the events that occur during tryptophan induction of tna operon expression. During induction, features of the TnaC-leader peptidyl-tRNA, most notably, Trp12 and Pro24 (1, 8), create a tryptophan binding site in the A site of the translating ribosome (1). Tryptophan binds at this site, interfering with RF2 action and preventing the cleavage of the newly synthesized TnaC-
. RF3 and RRF then slowly bind to the ribosome and promote TnaC-
dropoff from the ribosome. Pth then hydrolyzes the released TnaC-
, freeing
for additional rounds of protein synthesis. The release of TnaC-
also allows ribosome dissociation from the transcript. Our results raise several additional questions. How is tmRNA prevented from acting on TnaC-
? What roles do RF3 and RRF play during the liberation of TnaC-
? Additional studies will be required to answer these questions and identify the exact site(s) and mechanism(s) of action of the various translation termination factors.
These studies were supported by National Science Foundation grants MCB-0093023 and MCB-0615390 to C.Y.
Published ahead of print on 9 February 2007. ![]()
Present address: Department of Biology and Biochemistry, UCLA Medical School, Los Angeles, CA 90095. ![]()
|
|
|---|
availability. J. Bacteriol. 188:1892-1898.This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»